Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NITRIC Cause Product use in unapproved indication? 190 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 190 reports of Product use in unapproved indication have been filed in association with NITRIC (Ulspira). This represents 6.2% of all adverse event reports for NITRIC.

190
Reports of Product use in unapproved indication with NITRIC
6.2%
of all NITRIC reports
119
Deaths
12
Hospitalizations

How Dangerous Is Product use in unapproved indication From NITRIC?

Of the 190 reports, 119 (62.6%) resulted in death, 12 (6.3%) required hospitalization, and 14 (7.4%) were considered life-threatening.

Is Product use in unapproved indication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NITRIC. However, 190 reports have been filed with the FAERS database.

What Other Side Effects Does NITRIC Cause?

No adverse event (771) Device malfunction (553) Device issue (424) Underdose (398) Product use issue (332) Death (314) Drug ineffective (192) Oxygen saturation decreased (169) Off label use (166) Condition aggravated (122)

What Other Drugs Cause Product use in unapproved indication?

DUPILUMAB (33,452) DICLOFENAC (12,197) METHOTREXATE (8,930) PREDNISONE (7,625) RITUXIMAB (7,519) MYCOPHENOLATE MOFETIL (5,910) ACETAMINOPHEN (5,819) CYCLOPHOSPHAMIDE (5,750) RISPERIDONE (5,551) TACROLIMUS (5,057)

Which NITRIC Alternatives Have Lower Product use in unapproved indication Risk?

NITRIC vs NITROFURANTOIN NITRIC vs NITROFURANTOIN\NITROFURANTOIN NITRIC vs NITROFURAZONE NITRIC vs NITROGLYCERIN NITRIC vs NITROUS

Related Pages

NITRIC Full Profile All Product use in unapproved indication Reports All Drugs Causing Product use in unapproved indication NITRIC Demographics